Health Indicators

INDICATOR	YEAR	UNIT	VALUE
ُEstimated population (Lebanese)	2017	1000 citizens	4,421
Total area		Km²	10,452
Population growth rate	2017		1.5
Life expectancy	2012	Years	81.24
Population <15	2017	Percent	24.6
Population > 65	2017	Percent	9.7
Total GDP	2017	Billion US$	53.4
GDP per Capita	2017	US $	12,078
THE per Capita	2015	US $	863
THE % GDP	2015	Percent	7.41
OOP % THE	2015	Percent	32.7
Physicians	2017	Per 10 000 population	31.3
Nurses	2017	Per 10 000 population	34
Midwives	2017	Per 10 000 population	2.4
Dentists	2017	Per 10 000 population	15.2
Beds	2016	Per 10 000 population	27.3

...

125

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G02CX01	TRACTOCILE	B	Atosiban acetate - 7.5mg/ml	7.5mg/ml	Injectable solution	2,592,272 L.L
L04AC19	ENSPRYNG	BioTech	Satralizumab - 120mg/ml	120mg/ml	Injectable solution	857,061,795 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 2000IU Anti-XA/0.2ml	2000IU Anti-XA/0.2ml	Injectable solution	1,105,982 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	153,990 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS R	G	Potassium chloride - K+:1.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.40 mmol/l, Sodium acetate - Cl-:105.8 mmol/l, Sodium chloride - Na+:140.5 mmol/l		Injectable solution	L.L
G02CX01	TRACTOCILE	B	Atosiban acetate - 7.5mg/ml	7.5mg/ml	Injectable solution	8,282,804 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 2000IU Anti-XA/0.2ml	2000IU Anti-XA/0.2ml	Injectable solution	388,370 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	189,262 L.L
B05ZA	CONCENTRATE SOLUTIONFOR HEMODIALYSIS TYPE A	G	Hemodialytics, concentrates -		Injectable solution	L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	14,719,570 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 2,000UI (20mg)/0.2ml	2,000UI (20mg)/0.2ml	Injectable solution	467,657 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	182,720 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE B+	G	Hemodialytics, concentrates -		Injectable solution	L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable solution	L.L
B01AB05	PARINOX 20	BioTech	Enoxaparin sodium - 2000IU (20mg)/0.2ml	2000IU (20mg)/0.2ml	Injectable solution	188,138 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	207,894 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE J	G	Hemodialytics, concentrates -		Injectable solution	L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 10000IU Anti-XA/1ml	10000IU Anti-XA/1ml	Injectable solution	1,209,458 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	198,578 L.L
B06AC05	TAKHZYRO	BioTech	Lanadelumab - 300mg/2ml		Injectable solution	1,204,227,927 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	226,036 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 40mg/ml	40mg/ml	Injectable solution	L.L
B05BB02	DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	194,211 L.L
L01FG01	ZIRABEV	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	14,800,115 L.L
B01AB12	HIBOR	G	Bemiparin Sodium - 2,500IU	2,500IU	Injectable solution	704,173 L.L
B05BB02	DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	180,421 L.L
L01FG02	CYRAMZA	BioTech	Ramucirumab - 100mg/10ml	100mg/10ml	Injectable solution	47,779,251 L.L
L04AA52	KESIMPTA	BioTech	Ofatumumab - 20mg/0.4ml	20mg/0.4ml	Injectable solution	L.L
B01AB12	HIBOR	G	Bemiparin Sodium - 3,500IU	3,500IU	Injectable solution	1,029,383 L.L

...

125

...